GemPharmatech Co., Ltd. (SHSE: 688046)
Health Care · Life Sciences Tools & Services · CN
CN¥34.63
-8.72% today · +110.4% 1Y
GemPharmatech Co., Ltd. (SHSE: 688046) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $2.12B.
Over the last twelve months the share price has gained 110.4%, trading between 12.89 and 43.47.
Tweenvest scores GemPharmatech Co., Ltd. across four factors: quality 69/100, value 14/100, growth 76/100, dividend 48/100. Its strongest factor is growth.
688046 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.12B
- Revenue (TTM)
- $129.27M
- P/E
- 76.68
- EPS
- 0.45
- Dividend yield
- 0.64%
- Beta (5Y)
- 0.87
- 52-week high
- CN¥43.47
- 52-week low
- CN¥12.89
- Avg volume (3M)
- —
- Shares outstanding
- 409.16M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sai Life Sciences LimitedNSEI: SAILIFE | $3.27B | Rs1,487.90 | -3.46% |
| Shanghai Haoyuan Chemexpress Co., Ltd.SHSE: 688131 | $2.97B | CN¥93.16 | -6.34% |
| Oxford Nanopore Technologies plcLSE: ONT | $2.75B | £2.17 | +1.69% |
| HitGen Inc.SHSE: 688222 | $2.48B | CN¥41.45 | -1.12% |
| Shanghai InnoStar Bio-tech Co., Ltd.SHSE: 688710 | $2.10B | CN¥99.80 | -5.13% |
| AddLife AB (publ)OM: ALIF B | $2.06B | Skr169.00 | +1.14% |
| Shanghai Medicilon Inc.SHSE: 688202 | $2.04B | CN¥104.00 | -1.73% |
| LigaChem Biosciences Inc.KOSDAQ: A141080 | $2.01B | ₩73,300.00 | -10.94% |
Figures last refreshed Oct 11, 2026.